Confocal Endomicroscopy for GI Neoplasia Study
This study has been completed.
Information provided by (Responsible Party):
Michael Wallace, Mayo Clinic
First received: January 10, 2012
Last updated: May 15, 2013
Last verified: May 2013
The purpose of this study is to enhance probe stabilization using a 4mm clear cap attached to endoscope in comparison to standard "free-hand" image acquisition.
||Observational Model: Cohort
Time Perspective: Prospective
||Confocal Endomicroscopy for GI Neoplasia Study
Primary Outcome Measures:
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||November 2012 (Final data collection date for primary outcome measure)
The aim of this study is to optimize and validate in-vivo imaging systems capable of highly accurate, real-time classification of colorectal neoplasia.
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Approximately 40 patients with polyps
- Those patients undergoing colonoscopy for screening or surveillance of colon polyps will be included in this study.
- Patients with known polyposis syndromes, inflammatory bowel disease, allergy to fluorescein, or refusal to provide informed consent.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01515514
|Mayo Clinic Florida
|Jacksonville, Florida, United States, 32224 |
||Michael B Wallace, MD,MPH
||Mayo Clinic Florida
No publications provided
||Michael Wallace, Primary Investigator, Mayo Clinic
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 10, 2012
||May 15, 2013
||United States: Institutional Review Board
Keywords provided by Mayo Clinic:
ClinicalTrials.gov processed this record on March 26, 2015
inflammatory bowel disease